Cipla's Indore plant under USFDA scanner over norms violations
Pharmaceutical major Cipla's shares dropped by 2.13 percent Tuesday amid speculation that the company's Indore plant has come under the scanner of US health regulator for manufacturing norms violations.
Oct 20, 2015, 18:31 PM IST
Cipla to launch generic Hepatitis C drug 'Hepcvir' in India
Drug major Cipla on Wednesday announced the launch of generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name 'Hepcvir', in India.
Mar 25, 2015, 15:37 PM IST
Cipla gains after April-June margins expand sequentially
Shares in drugmaker Cipla gain after April-June operating margins beat some estimates.
Aug 18, 2014, 12:33 PM IST
